AN & AN GLOBAL LIMITED

Creating access to innovative and affordable products and technology, strategic advice, and data analytics in the management of the COVID-19 pandemic. Providing access to an array of approved, validated and affordable COVID-19 test products - supported by an on-the-ground team to ensure quality control. In collaboration with laboratories, manufacturers and R&D centres in the United States, United Kingdom, and Asia - in addition to an expanding global sales network. Originating from a background in the pharmaceutical industry, our team is experienced in high-throughput manufacturing, registration, product branding and clinical trial management.

At our company, we provide custom lateral flow development and manufacturing services for a variety of industries and applications. Our mission is to provide precision, quality, and efficiency to our clients, ensuring that their lateral flow devices meet their specific requirements and exceed their expectations. We are committed to providing our clients and the broader community with educational materials that are informative and easy to understand. As an EU-based biotechnology innovator, we specialize in crafting ELISA and Lateral Flow Tests for the food, feed, beverage, agriculture, and clinical diagnostics sectors. Dive into the world of safety, accuracy and precision with our industry-leading diagnostic devices. The products offered by ProGnosis Biotech have been validated by the most highly regarded organizations worldwide, and all R&D and production procedures are ISO 9001:2015 and ISO 13485:2016 accredited. ProGnosis Biotech provides everyone with an easy and accurate way to diagnose and stop the spread of disease. The innovative ATP testing offers real-time insights achieving quality control and compliance with safety standards.

We are lateral flow technology experts and as a Contract Research Organisation (CRO) and Contract Development & Manufacturing Organisation (CDMO) we support our customers on the path to commercialisation. In essence, we provide our customers with a comprehensive lateral flow service solutions to take their diagnostics projects from idea to commercial success. We are experts in design for manufacture, reagent assessment & evaluation of materials for prototype development for Proof of Concept & Optimisation of your device to Design Freeze. We believe by developing high quality, effective lateral flow rapid tests combined with our manufacturing experience and scale, we can provide the means to accelerate access to rapid testing. With an exceptional pedigree in developing and manufacturing rapid tests Abingdon Health specialise in responding to our customers varied needs with specific and customisable solutions. By providing the best lateral flow rapid test solutions, we believe we can support the increase in access to diagnostics across many industries and locations. Abingdon Health is committed and honest in all that we do. By working with customers, suppliers, technology partners and colleagues, we are better together.

We develop innovative, quality, custom rapid lateral flow immunoassay tests - from antibody and protein development to production. We are the world’s first full-suite social enterprise diagnostics company, re-investing 100% of our profits to increase access to diagnostics for people who need them the most. One mission unites our products: to put quality and affordable testing closer to the people that need them. Lateral flow technology offers people an opportunity to take care of themselves with a simple and affordable way to understand their health at point-of-need. Unfortunately, many diseases can only be tested with expensive equipment in a laboratory, operated by people with technical knowledge and expertise, and on samples that require transport to the facility. Driven by need and not profit, our mission is to get the best testing, to the most people, for the lowest cost. Partnering with GADx gives you access to our world-leading team. Our flexible manufacturing service is specialised in delivery of high quality, rapid diagnostics to make the detection and treatment of disease affordable for everyone.

We are a diverse team that includes collaborators and advisors from around the world. Our mission is to reduce the global impact of infectious diseases through the development of affordable innovative products, with a special focus on those diseases affecting people in low- and middle income countries. We are exploring non-pharmaceutical uses for our core technology, including vector control and laboratory safety. Expert in the chemistry of natural products and drug discovery. Over 40 years of experience in the pharmaceutical industry.

We are scientists from across the world seeking to support each other in accessing reagents for research and diagnostics, through sharing and partnership.